Hematology / Oncology
Title
Date Published
Anastomotic Leakage Contributes to the Risk for Systemic Recurrence in Stage II Colorectal Cancer.
November 18, 2010
Assessment of fatigue after blood transfusion in palliative care patients: a feasibility study.
October 25, 2010
Transfusion and NHL risk: a meta-answer?
October 21, 2010
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy–results from the randomized DAHANCA 5 study.
October 20, 2010
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
October 13, 2010
Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients.
October 1, 2010
Indication for platelet transfusion in patients with haematological diseases: less is more. [Article in German]
September 14, 2010
The oncology treatment of patients who use oral anticoagulants is connected with high risk of bleeding complications.
August 1, 2010
Epoetin beta for the treatment of chemotherapy-induced anaemia in solid and haematological malignancies. Results of an open-label, multicentric clinical trial [Article in French]
August 1, 2010
Current and future management options for myelodysplastic syndromes.
July 30, 2010
Delayed spontaneous remission in a child with primary acquired chronic red cell aplasia.
July 8, 2010
Disseminated intravascular coagulation in hematologic malignancies.
July 7, 2010
First report of successful stem cell transplantation in a patient with sickle cell hemoglobin D disease.
July 1, 2010
Adverse drug reactions affecting blood cells
June 30, 2010
Hydroxyurea in sickle cell disease: What will it take to change practice?
June 1, 2010
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
June 1, 2010
Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
May 24, 2010
Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival.
May 1, 2010
Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura.
April 6, 2010
Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab.
March 1, 2010